Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
A J Clin Psychiatry commentary proposes a risk-benefit matrix favoring empiric catatonia treatment when diagnostic uncertainty exists, citing the syndrome’s high morbidity and the effectiveness of available interventions.
Emergency Medicine May 13th 2026
Epoch Health
Viatris recalled one lot of Xanax XR 3-mg extended-release tablets after failed dissolution testing, with the FDA classifying the action as Class II and reporting no adverse events to date.
Family Medicine/General Practice April 29th 2026
Cleveland Clinic Journal of Medicine (CCJM)
Deprescribing benzodiazepines in patients on long-term stable treatment led to increased mortality along with increases in nonfatal overdoses, suicidal ideation, and emergency department visits.
Psychiatry January 21st 2026